Originally posted by jsun529
View Post
Unconfigured Ad
Collapse
This topic is closed.
X
This is a sticky topic.
X
X
-
what is the definition of the header line in SOLiD csfasta file, eg
1_88_1830_R3 -- What is 88, 1830 stands for ? Thanks
Leave a comment:
-
Hi Dinny,
I think there is also a way to get Bowtie to produce it's own alignment in .map format, if I recall correctly.
Anyhow, if you're working with SET, you can also convert the bowtie reads directly to .bed: https://sourceforge.net/apps/mediawi...e=ConvertToBed
Leave a comment:
-
Thanks very much Anthony and ewilbanks.
I looked closer at Bowtie conversion tools and I can create a .map file from the alignment (I'm working with single-end reads), but I have to get Maq working to do it. I'll give it a go, and compare Maq alignment times while I'm at it ;-)
Cheers,
Dinny
Leave a comment:
-
I don't think that CisGenome has support for bowtie output yet. Best bet would be to find scripts to convert to .bed or .aln
Leave a comment:
-
Hi Dinny,
Findpeaks can use bowtie's reads - but it depends if you want to use PET or SET tags. if you're using PET, you'll need to convert your reads into BED format, which is the only way that you can retain the pairing information. If you're using SET, you should be able to bet Bowtie to produce a .map file (if I recall correctly), which can then be processed natively by FindPeaks.
If you need help with findPeaks, you can always send an email to the mailing list - I tend to reply more quickly to those inquiries than those on SeqAnswers.
Cheers,
Anthony
Leave a comment:
-
Hi all,
Thanks for the helpful list. Based on reading the post I've tried out Bowtie to align reads from a ChIP-seq experiment run on Illumina GA-II (the facility gave me non-aligned fastq). Worked great!
I want to put the output into cisGenome or FindPeaks (or both). Can anyone advise me how to get it into the right format? Does FindPeaks convert any of the output options in Bowtie?
Thanks
Leave a comment:
-
Beta version of the SEQwiki software database up and running...
Check it out...
http://seqanswers.com/wiki/SEQanswers
http://seqanswers.com/wiki/Software
Dan.
Leave a comment:
-
Great list!
I'd like to introduce some code I'm working on. I don't know if it deserves to go into the list, but it might be of some use for someone. Is not finished yet, but if someone is interested in trying it out or in working on it just let me know.
You can find it at biolib.
It's a library and a set of script targeted to NGS. There are modules to:
- clean sequences (sanger, 454, ilumina).
- parse caf, ace and bowtie map files.
- clean and filter contigs.
- look for snps and indels.
- filter snps.
- do statistics for: reads, contigs and snps.
Be aware that it's just a work in progress and its in constant flux. The code is available under the AGPL.
Leave a comment:
-
Thanks for your useful post.
I’m interested in ABySS and I installed it on my linux server.
However, I knew it does not use a reference genome, as it is a de novo assembler.
I think it should be moved from "Align/Assemble to a reference" category to "De novo Align/Assemble" category.
Cheers! ^^
Leave a comment:
-
Further to the above, if you're a molecular biologist without coding skills it is far easier to stick to commercial integrated solutions however you may feel constrained by lack of features within the software if your application is anything other than vanilla.
If you embark upon the open source route you'll need skills in UNIX shell scripting/Perl/SQL. If you don't have them get a bioinformatician onboard. If you need to do 'counting' methods such as RNA-Seq, CHiP-Seq, Bis-Seq, etc then it is probably wise to consult a biostatistician.
Leave a comment:
-
Hi hrajasim,
That's a very open ended question, depending very strongly on what type of analysis you'd like to do. As far as I'm aware, the cutting edge development for NGS is happening in open source, so you'll probably want to fill major parts of the pipeline with open source (Eg, aligners, format converters, ChIP-Seq analysis, assembly, etc)
However, any time you're contrasting open source versus a commercial product, you have to ask the right questions:
Is there a feature set that I absolutely need?
Will I require support for the software beyond the forums and available community?
Will I want to make modifications to the source code and customize it for the pipeline?
Without knowing what you plan to do with the software, it will be impossible for us to figure out which path is best for you.
Cheers!
Leave a comment:
-
Open source Vs Commercial
Hi Folks, I an new to NGS and am tasked to evaluate commercial and open source alternatives to analyse NGS data. Looking at the pretty comprehensive list in this post (which is very useful) I am not able to make out whether we really need to pay for a solution such as Genomatix or can we do away with just the free open source tools?
Please comment or share your thoughts in this regard.
I Appreciate your time and inputs.
Thanks,
Leave a comment:
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
Leave a comment: